TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Terminated

Nebivolol Versus Carvedilol in Patients With Heart Failure

BACKGROUND Beta-blockers improve left ventricular (LV) systolic function and prognosis in patients with chronic heart failure. Both carvedilol and nebivolol have hemodynamic and clinical benefits in chronic heart failure (CHF), but it is un

Rome, rome, ItalyView details
CompletedPhase 3

The Congestive Heart Failure Adherence Redesign Trial

The purpose of this study is to test whether a culturally sensitive self-management (SM) intervention, compared to an education only control, will reduce all-cause hospital days in patients with mild to moderate heart failure and household

Chicago, Illinois, United StatesView details
Not yet recruitingPhase 3

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial

The ISCHEMIA-HF trial will randomize participants with multivessel coronary artery disease (CAD) with ejection fraction (EF) ≤40% in a 1:2:2 fashion to guideline-directed medical therapy (GDMT):coronary artery bypass grafting (CABG):percuta

New York, New York, United States+5 moreView details
TerminatedN/A

Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure

The INTERVENE-HF study is a prospective, non-randomized, multi-center (US only), investigational, feasibility study. The purpose of this study is to characterize safety of managing heart failure patients with integrated device diagnostics t

Phoenix, Arizona, United States+7 moreView details
CompletedN/A

The Effect of Medium-chain Fatty Acids on Cardiac Function

The effect of an acute intake of medium-chain fatty acids on heart function measured by cardiac magnetic resonance imaging (CMR) will be measured in individuals with heart failure with reduced ejection fraction (HFrEF) and in matched health

Copenhagen, DenmarkView details
CompletedN/A

Compare Remote Patient Management and Standard Care in CRT-D and ICD-patients to Assess the Effect on Heart Failure

This pilot study is to prospectively evaluate the benefit of clinicians being able to access ICD device information in a timelier manner and treat fluid overload with a pre-defined pattern using the Medtronic OptiVol, Medtronic CareAlerts a

Göttingen, GermanyView details
CompletedPhase 3

Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction

The instigators hypothesize that IVIG, given in the acute phase following MI in patients at risk for developing HF, will improve cardiac performance, and by attenuating cardiac remodeling in this phase, such therapy will prevent the develop

Oslo, NorwayView details
UnknownPhase 4

Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fraction

Beta blockers have been used to reduce the mortality and heart failure rehospitalization in heart failure with reduced ejection fraction (HFrEF) patients in addition to ACEI/ARB, MRA, ivabradine and ARNI. However, the effective and safe med

Seoul, South KoreaView details
Recruiting

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure

Heart failure (HF) patients often develop pulmonary hypertension (PH) that leads to transition into a biventricular HF with poor prognosis. There are two PH components: 1) passive transmission of increased left atrial pressure, 2) heart fai

Prague, CzechiaView details
Completed

Time Course Evolution of Cardiac Output

Fluid expansion is the first therapeutic option in patients presenting acute circulatory failure but the duration of its hemodynamic effects (persistency and time of maximal increase in cardiac output) is unknown. This study is seeking to d

Multiple locationsView details
TerminatedN/A

Biventricular Pacing After Cardiopulmonary Bypass

The purpose of this study is to investigate the efficacy of optimized temporary biventricular pacing (BiVP) in patients undergoing open-heart surgery with preoperative LV dysfunction and an intraventricular conduction delay. This study will

New York, New York, United StatesView details
Completed

Primary Prevention of Sudden Cardiac Death (PREV-DEATH)

The efficacy of implantable cardioverter-defibrillators (ICD) in primary prevention of sudden cardiac death (SCD) is well demonstrated but pivotal studies have been published more than 10 years ago and implantation's conditions tend to chan

Metz, FranceView details
CompletedN/A

Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones

The overarching goal of the project is to improve the process and experience of surrogate decision-making by family caregivers. Since feeling unprepared to make surrogate decisions is a major contributor to caregiver stress, the primary out

Boston, Massachusetts, United States+1 moreView details
Not yet recruitingN/A

TRAnscutaneous vaGUS Nerve Stimulation in Patients With Chronic Heart Failure

To verify the efficacy of transcutaneous vagus nerve stimulation (tVNS) on and autonomic balance in patients with chronic heart failure and reduced (HFrEF) or mildly reduced (HFmrEF) left ventricular ejection fraction. The study hypothesis

Pisa, Pi, ItalyView details
CompletedPhase 4

Impact of Beta-blockers on Physical Function in HFpEF

The purpose of this study is to understand the impact of beta-blockers on physical function in older adults with heart failure. We will achieve this objective by conducting N-of-1 trials.

New York, New York, United StatesView details
Unknown

Right VEntricular Contractile ReSERVE in Functional Tricuspid Regurgitation

Aim of the study is to investigate the prognostic value of right ventricular contractile reserve in patients with functional tricuspid regurgitation undergoing tricuspid valve repair or replacement.

Leipzig, GermanyView details
RecruitingN/A

A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure

Chronic Kidney Disease often requires dialysis and other treatments to sustain life, and patients frequently suffer from heart failure, which exacerbates the disease burden. Research has shown that the incidence of heart failure is high amo

Guangzhou, Guangdong, ChinaView details
CompletedN/A

Pacemaker Upgrade to Cardiac Resynchronisation Therapy in Patients With Left Ventricular Dysfunction Dependant Upon Right Ventricular Pacing

Patients with pacemakers often have undiagnosed heart muscle weakness. When a pacemaker battery has run down, it is easily replaced by a short procedure.

Leeds, United KingdomView details
TerminatedPhase 2 / Phase 3

Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)

The purpose of this study is to assess the efficacy and safety of implanting an Edwards Sapien XT Valve into the vena cava inferior (VCI; between right atrium and the hepatic vein) on clinical variables, exercise tolerance and well being in

Berlin, GermanyView details
CompletedN/A

Mediterranean Diet and Nutritional Support in Heart Failure Sarcopenia

Heart failure (HF) is a chronic disease with an increasing incidence; it represents the final stage of multiple cardiac diseases and significantly affects the QoL of the patients. Its prevalence is about 26 million people in the world, espe

Córdoba, Cordoba, SpainView details
Load more trials